Evaluation of Lupus Cases Related to TNF Inhibitors in Children
The Journal of Pediatric Academy · 2023
DOI: 10.4274/jpea.2023.226 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pediatric Academy, 2023. Verfasst von Şeyma Türkmen und 2 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) due to anti-tumor necrosis factor (TNF) agents is a rare entity. We reported three cases who developed lupus-like syndrome while receiving infliximab therapy for various reasons. All cases demonstrated clinical and laboratory findings of SLE. And all of them needed treatment. We would like to emphasize that the risk of anti-TNF-alpha-induced lupus should be kept in mind in patients receiving anti-TNF therapy for any reason.
Zitieren
APA
Türkmen, Ş., Gerenli, N., & Sözeri, B. (2023). Evaluation of Lupus Cases Related to TNF Inhibitors in Children. The Journal of Pediatric Academy. https://doi.org/10.4274/jpea.2023.226
Vancouver
Türkmen Ş, Gerenli N, Sözeri B. Evaluation of Lupus Cases Related to TNF Inhibitors in Children. The Journal of Pediatric Academy. 2023. doi:10.4274/jpea.2023.226
BibTeX
@article{Trkmen2023,
author = {Türkmen, Şeyma and Gerenli, Nelgin and Sözeri, Betül},
title = {Evaluation of Lupus Cases Related to TNF Inhibitors in Children},
journal = {The Journal of Pediatric Academy},
year = {2023},
doi = {10.4274/jpea.2023.226}
}
EUVIMED